Barbara Wilirnczyk-Macri
FDA investigator
Appears on 1 document from 2013, mostly at sites in New Jersey. Most often cites control of microbiological contamination (21 CFR 211.113).
- 1
- Documents on file
- 11.0
- Observations per 483
- 2013
- First seen
- 2013
- Most recent
What they cite most
From 11 observations- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.167Special testing requirements2
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.188Batch production and control records1
- 21 CFR 211.198Complaint files1
- 21 CFR 211.22Responsibilities of quality control unit1
Activity by year
2013: 1
Where
New Jersey 1
Often inspects with
Is Barbara Wilirnczyk-Macri coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2013-02-11 | 483 Wedgewood Village Pharmacy, Inc.Feb 11, 2013 · Swedesboro, New Jersey | Swedesboro, New Jersey | 11 |
About this profile
What does Barbara Wilirnczyk-Macri inspect?
Barbara Wilirnczyk-Macri appears on 1 document on file covering 1 site, mostly in New Jersey.
What do they cite most often?
21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.167 and 21 CFR 211.100.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Barbara Wilirnczyk-Macri is dated Feb 11, 2013.